Post SIV Clinical Trial Process From The Perspective Of A Sponsor Or CRO

Developing a protocol and finding suitable sites to conduct study related procedures is only the first step to getting a new medication out in the market. After a selection, an initiation visit must occur in order to prepare sites to screen their first patients. After each site reaches a screening or randomization milestone, sites must be monitored in order to prevent deviations, and identify any problems that sites may have encountered during patient visits.

Comment